The seroprevalence of human papillomavirus by immune status and by ethnicity in London
Open Access
- 14 September 2009
- journal article
- research article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 4 (1) , 14
Abstract
The natural history of cutaneous HPV is unclear and in particular, seroprevalence among individuals with different levels of immune function and ethnicity is unknown. As part of a study of cutaneous squamous cell carcinoma (SCC) and HPV among organ transplant recipients (OTR) from London, we investigated the seroprevalence and risk factors for 34 HPV types (detected using Luminex technology) among 409 OTR patients without skin cancer (243 Caucasians and 166 non-Caucasians), 367 individuals with end stage renal failure on dialysis (222 Caucasians and 145 non-Caucasians) and 152 immunocompetent (IC) individuals without skin cancer (102 Caucasians and 50 non-Caucasians) to compare the HPV seroprevalence in patients with differing immune status and ethnicity. In total, seroprevalence data from 928 individuals, all from London, was available. Overall, no difference between HPV seroprevalence by immune status was observed (P = 0.3) among Caucasian or among non-Caucasian individuals, with seroprevalence varying from 87% to 94% across different immune status and ethnic groups. Those individuals seropositive to multiple types of one genus were more likely to be seroreactive to multiple types of another genus, independent of immune status or ethnicity. Lower seroprevalence for gammaHPV 4, and to a lesser extent gammaHPV 48, were observed among OTR compared to IC and dialysis patients. Higher seroprevalence against antibodies to betaHPV 93 were detected more frequently in non-Caucasians than Caucasians whereas muHPV 1 and, to a lesser extent, gammaHPV 4 were found more frequently among Caucasians - these findings were independent of immune status. Within non-Caucasian subgroups, the seroprevalence of 8 HPV (alpha-mucosal HPV16 and 13, alpha-cutaneous HPV7 and 2, betaHPV8, 17, 23 and 38) was significantly (P < 0.02) higher in Black compared to Asian patients. HPV16 being sexually transmitted, this might suggest a potential sexual route of transmission for some beta HPV types. We did not observe major disturbance in antibody response between immunocompetent, dialysis and OTR individuals, but significant differences in HPV seroprevalence were identified according to ethnicity. Further research is needed to clarify the natural history of cutaneous HPV, particularly given the growing research interest in its possible role in the pathogenesis of cutaneous SCC.Keywords
This publication has 17 references indexed in Scilit:
- Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and AustraliaJournal of General Virology, 2009
- A case‐control study of cutaneous squamous cell carcinoma among Caucasian organ transplant recipients: The role of antibodies against human papillomavirus and other risk factorsInternational Journal of Cancer, 2009
- Seroprevalence of 34 Human Papillomavirus Types in the German General PopulationPLOS Pathogens, 2008
- A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 2007
- Suppression of non-specific binding in serological Luminex assaysJournal of Immunological Methods, 2006
- Multiplex Human Papillomavirus Serology Based on In Situ–Purified Glutathione S-Transferase Fusion ProteinsClinical Chemistry, 2005
- The interrelation of demographic and geospatial risk factors between four common sexually transmitted diseasesSexually Transmitted Infections, 2005
- Seroprevalence of Human Papillomavirus Type 16 Infection in the United StatesThe Journal of Infectious Diseases, 2002
- Molecular aspects of T – and B-cell function in uremiaKidney International, 2001
- Geomapping of chlamydia and gonorrhoea in BirminghamSexually Transmitted Infections, 2000